About ▼ Careers Internship MedBlog Contact us

LOGIN REGISTER

Medindia » News » Drug News » FDA Certifies Novel ADHD Drug

FDA Certifies Novel ADHD Drug

by Savitha C Muppala on Feb 26 2007 8:04 PM

Washington - The FDA has permitted the use of a new drug to treat attention deficit hyperactivity disorder. The drug known as Vyvanse, is manufactured by Shire PLC.

Washington - The FDA has permitted the use of a new drug to treat attention deficit hyperactivity disorder. The drug known as Vyvanse, is manufactured by Shire PLC.

The company hopes that patients can have a smooth transition from the older ADHD medications to Vyvanse.

The company has further confirmed that the present drug is promising because it is difficult to abuse. The effect of this drug is best realized only when it is swallowed.

Source-Medindia
SAV

Recommended Readings

Dysgraphia / Disorder of Written Expression / Writing Disorder

Dysgraphia / Disorder of Written Expression / Writing Disorder

Dysgraphia or disorder of written expression is a childhood learning disorder marked by poor writing skills. It may occur alone or along with other disabilities such as speech problems and attention deficit disorder.

Dyslexia

Dyslexia is a reading disability that occurs when the brain does not properly recognize and process certain symbols.

Diet to control Attention Deficit Hyperactivity Disorder

Diet to control Attention Deficit Hyperactivity Disorder

Attention Deficit Hyperactivity Disorder (ADHD) is a neurological disorder that affects children of school going age and often subsides as the child matures.

Sensory Processing Disorder (SPD)

Sensory Processing Disorder (SPD)

Sensory processing disorder / SPD is a brain disorder that interferes with the ability to process sensory information. The disorder poses day-to-day challenges, and therefore, early intervention is ideal for prevention.

Adult Attention-Deficit Hyperactivity Disorder (ADHD)

Adult Attention-Deficit Hyperactivity Disorder (ADHD)

Adult attention-deficit hyperactive disorder (ADHD) is a mental health condition in adults seen as hyperactivity, impulsiveness and reduced attention. ADHD impairs social, academic, neuropsychological and occupational behavior.

Mind-wandering

Mind wandering is a spontaneous and unintentional shifting of attention of thoughts from a primary task that can happen in varying degrees.

Latest Drug News

FDA Approves Obe-cel CAR T Therapy for Relapsed B-cell ALL

FDA Approves Obe-cel CAR T Therapy for Relapsed B-cell ALL

Explore the groundbreaking obe-cel CAR T cell therapy for relapsed B-cell ALL, showcasing high efficacy and FDA approval as a promising treatment option.

Study Finds Popular Diabetes and Obesity Drugs Also Safeguard Kidneys

Study Finds Popular Diabetes and Obesity Drugs Also Safeguard Kidneys

A new study shows GLP-1 receptor agonists offer significant protection for kidneys and heart in both diabetic and non-diabetic individuals.

Pink Cocaine: The Party Drug With a Deadly Twist

Pink Cocaine: The Party Drug With a Deadly Twist

Pink cocaine: the glamorous party drug trend with a fatal twist. It is typically a powdered blend of ketamine and illicit substances, often dyed with food coloring.

Appetite Suppressants and Food Surplus: An Unexpected Link

Appetite Suppressants and Food Surplus: An Unexpected Link

New insights reveal how anti-obesity drugs may contribute to food waste by reducing appetite, leading to uneaten food and increased disposal.

Parkinson's Drug Alters Gut Microbiome Negatively, Linked to Iron Deficiency

Parkinson's Drug Alters Gut Microbiome Negatively, Linked to Iron Deficiency

Parkinson's drug linked to harmful gut microbiome changes, potentially caused by iron deficiency, may worsen gut health and impact treatment outcomes.

Advertisement